This evaluation for the KFF-Peterson Well being System Tracker compares the very first Medicare negotiation drug costs beneath a brand new course of created by the Inflation Discount Act of 2022 present US checklist costs, costs negotiated by the Division of Veterans Affairs (VA)And costs in 11 nations from comparable measurement and wealth.

It finds that Medicare's negotiated costs for ten high-priced pharmaceuticals are decrease than what non-public Medicare drug plans had paid, however nonetheless a lot increased than costs accessible in different nations – on common 78% greater than the nation with the following highest worth in eleven different wealthy nations.

The evaluation is on the market on the Peterson-KFF Well being System Tracker, a web-based useful resource middle devoted to monitoring and assessing the efficiency of the U.S. well being care system.